Group 1 - The announcement details the pledge and release of shares by the controlling shareholder, Chengdu Enwei Investment (Group) Co., Ltd., which holds 29,733,200 shares, accounting for 28.90% of the company's total share capital as of June 20, 2025 [2] - The total number of pledged shares exceeds 50% of the shares held by the shareholder and its concerted parties, with 14,890,836 shares maturing in the next six months, representing 21.10% of their holdings and 14.47% of the total share capital, with a corresponding financing balance of 13.38 million [2] - The company confirms that the pledge does not affect its operations, governance, or financial stability, and there are no non-operational fund occupations or violations that harm the company's interests [2][3] Group 2 - The financial condition of the shareholder is reported to be good, with sufficient repayment capability, and there is no risk of forced liquidation or transfer of pledged shares [3] - The company commits to timely disclosure of any significant changes regarding the pledged shares in accordance with legal and regulatory requirements [4]
恩威医药股份有限公司关于控股股东部分股份质押及解除质押的公告